A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
Conditions:   Primary Open Angle Glaucoma;   Ocular Hypertension Interventions:   Drug: CKD-351;   Drug: Latanoprost+Dorzolmamide Sponsor:   Chong Kun Dang Pharmaceutical Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 25, 2020 Category: Research Source Type: clinical trials